Join us for our next Living Room Talk on AI in Health!

Al in Health 12th May at 12 PM CEST

Artificial Intelligence is increasingly making inroads in healthcare applications, although the field is still in its initial applications. During this one-hour Living Room Talk, find out from AI expert Angelo Dalli how AI can assist doctors and medical practitioners in various ways, from better diagnoses, to drug discovery and constant intelligent pro-active monitoring. Learn about the vision for the future of AI in healthcare and the personalized approach that it can enable, leading to a better quality of life, and better, healthier outcomes for all of us.

The webinar will also feature a case study on SOM Biotech, a company that repurposes drugs using AI.

Angelo Dalli Bio 

Angelo Dalli is an AI expert and serial tech entrepreneur, combining deep technical ability with commercial acumen.

Angelo founded 9 startups, was involved in 4 IPOs, invested in numerous Technology, Entertainment and Fintech companies, and secured investments from EU funds, Angel Investors and VCs. Angelo is an EBAN member, WBAF senator and BAM president, and was twice named as Malta’s Top Entrepreneur of the Year in 2014 and 2019.

Holding a Ph.D. in Computer Science, Angelo authored over 23 papers about Artificial Intelligence, Language Processing and Search Engines. Angelo won a bronze medal at the 1995 International Olympiad in Informatics.

Raúl Insa

Dr. Raúl Insa has more than 20 years’ experience in multinational pharmaceutical companies, such as Parke-Davis (Pfizer), UCB Pharma, Uriach Group (Palau Pharma) and ISDIN (Esteve), working on drug development from drug identification to commercialization.

He received his Medical training and his PhD in Clinical Neurology at the University of Alicante, Spain; an MBA from ESADE Business School in Barcelona and an Executive Education Program from IESE, Barcelona. He has also attended a couple of biotech leadership programs from Harvard Business School, Boston. More than 45 publications and papers, 7 chapters in books, 87 congress communications and 12 pharmaceutical patents.

Register Here